Find your next favorite podcast

Become a member today and read free for 30 days
What Next: The Price of a Peanut Allergy: There are currently no FDA-approved treatments for a peanut allergy. A new drug was just recommended for approval.

What Next: The Price of a Peanut Allergy: There are currently no FDA-approved treatments for a peanut allergy. A new drug was just recommended for approval.

FromSlate Daily Feed


What Next: The Price of a Peanut Allergy: There are currently no FDA-approved treatments for a peanut allergy. A new drug was just recommended for approval.

FromSlate Daily Feed

ratings:
Length:
21 minutes
Released:
Sep 19, 2019
Format:
Podcast Episode

Description

A buzzy new drug to help treat people with a peanut allergy was recommended for approval by an FDA advisory board this week. It would be the first government-approved method intended to combat these kinds of allergic reactions. The story behind that drug helps explain how the cost of many prescription drugs ends up being so high.
Guest: James Hamblin, staff writer at The Atlantic.
Slate Plus members get bonus segments and ad-free podcast feeds. Sign up now.
Learn more about your ad choices. Visit megaphone.fm/adchoices
Released:
Sep 19, 2019
Format:
Podcast Episode